Japan PPI inflation slips to 11-mth low in July
Joseph Benesch, the Chief Financial Officer of Journey Medical (TASE:BLWV) Corp (NASDAQ:DERM), recently sold shares of the company’s common stock. According to a recent SEC filing, Benesch sold 1,365 shares on February 21, 2025. The shares were sold at a weighted average price of $5.19, amounting to a total transaction value of approximately $7,084. The $109 million market cap company has shown strong momentum, with shares up 32% year-to-date and trading near its 52-week high of $6.89.
The sale was conducted automatically to cover tax withholding obligations related to the vesting of restricted stock units. Following this transaction, Benesch holds 45,966 shares of Journey Medical Corp. The shares sold were part of a series of open market transactions executed by a broker-dealer, with sale prices ranging from $5.19 to $5.20. With Journey Medical’s next earnings report scheduled for March 20, InvestingPro subscribers can access detailed financial analysis and additional insights through the comprehensive Pro Research Report.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.